Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Cameron Snell

11PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Jan 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.

Madeline Gough, Kayden K X Kwah, Tashbib Khan

|Aug 17, 2024
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Jay Gunawardana, Soi C Law, Muhammed B Sabdia

|Jun 27, 2023
Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer.

Madeline Gough, Cheng Liu, Bhuvana Srinivasan

|Nov 19, 2021
Characterising <sup>18</sup>F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging.

N P Scott, E J Teoh, H Flight

|Aug 07, 2021
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression.

Martina Proctor, Jazmina L Gonzalez Cruz, Sheena M Daignault-Mill

|Aug 05, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.

Helen Sheldon, Esther Bridges, Ildefonso Silva

Pageof 2

Frequent Collaborators

2 joint publications

Adrian L Harris

2 joint publications

Colm Keane

2 joint publications

John D Hooper

2 joint publications

Thomas Kryza

2 joint publications

Madeline Gough

1 joint publications

S R Lord

1 joint publications

D R McGowan

1 joint publications

Aline Talhouk

1 joint publications

Elizabeth D Williams

1 joint publications

Sahar Keshvari

Frequent Collaborators

2 joint publications

Adrian L Harris

2 joint publications

Colm Keane

2 joint publications

John D Hooper

2 joint publications

Thomas Kryza

Top Related Videos

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on : Feb 03, 2023

1.4K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.7K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.7K
See more related videos

Top Related Videos

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on : Feb 03, 2023

1.4K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.7K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.7K
See more related videos